Alpha Cognition (ACOG) Net Equity Issued and Repurchased (2023 - 2024)
Alpha Cognition's (ACOG) quarterly Net Equity Issued and Repurchased came in at $3.7 million in Q1 2024, up 10.68% quarter-over-quarter from $3.4 million in Q4 2023.
Alpha Cognition (ACOG) Net Equity Issued and Repurchased (2023 - 2024) Analysis & Trends
Alpha Cognition's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $3.7 million for Q1 2024.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $3.7 million in Q1 2024; TTM through Dec 2024 was $3.7 million, a N/A change from a year earlier, with the FY2024 full-year figure at $3.7 million, down 59.53% from the prior year.
- Net Equity Issued and Repurchased climbed to $3.7 million in Q1 2024 per ACOG's latest filing, from $3.4 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $3.7 million in Q1 2024 and bottomed at $1.3 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Alpha Cognition | 145.51 Mn | 79.41 Mn | 2.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 3.73 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 3.37 Mn |
| Dec 31, 2023 | 3.37 Mn |
| Sep 30, 2023 | 1.35 Mn |
| Sep 30, 2023 | 1.35 Mn |